Literature DB >> 9657662

Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes.

S H Kuo1, D B Chang, Y C Lee, Y T Lee, K T Luh.   

Abstract

This study was carried out in order to investigate the local immune reaction of tumour-infiltrating lymphocytes (TILs) in the primary tumours of non-small cell lung carcinomas. Thirty non-small cell lung cancer (NSCLC) patients were included. The tumour tissue was taken at thoracotomy and monocellular suspension of the tumour was obtained by mechanical disaggregation. Dual-coloured flow cytometric analysis of TILs and their corresponding peripheral blood lymphocytes (PBLs) was performed. Tumour-infiltrating lymphocytes contained significantly higher proportions of CD3(+) T lymphocytes and CD8(+) T lymphocytes than the corresponding PBLs (82.0%+/-13.9% vs 66.3%+/-10.6% for CD3, P<0.001; 39.0%+/-18.4% vs 26.4%+/-5.2% for CD8, P<0.001). Tumour-infiltrating lymphocytes contained significantly higher proportions of activated memory lymphocytes than PBLs did (9.8%+/-8.6% vs 1.3%+/-1.5% for CD25, P<0.001; 40.5%+/-30.2% vs 10.2%+/-14.8% for CD71, P<0.001; 75.5%+/-11.9% vs 28.6%+/-9.8% for HLA-DR, P<0.001). These findings were also found in both CD4(+) TILs and CD8(+) TILs. The TILs of NSCLC contained higher proportions of T lymphocytes and CD8(+) lymphocytes than their corresponding peripheral bloods. The proportions of activated memory lymphocytes were also significantly higher in the TILs, both in CD4(+) TILs and CD8(+) TILs, than the corresponding PBLs.

Entities:  

Mesh:

Year:  1998        PMID: 9657662     DOI: 10.1046/j.1440-1843.1998.d01-9.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  3 in total

Review 1.  Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer.

Authors:  Junying Wang; Xueju Wang
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

2.  Prognostic significance of tumor-infiltrating CD8⁺ or CD3⁺ T lymphocytes and interleukin-2 expression in radically resected non-small cell lung cancer.

Authors:  Chuntao Tian; Shixin Lu; Qingxia Fan; Weijie Zhang; Shunchang Jiao; Xiao Zhao; Zhiyong Wu; Liang Sun; Liuxing Wang
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

3.  Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer.

Authors:  Edin Jusufovic; Besim Prnjavorac; Ermina Iljazovic; Mitja Kosnik; Dragan Keser; Peter Korosec; Jugoslav Stahov; Edin Zukic; Rifat Sejdinovic; Ekrem Ajanovic
Journal:  Acta Inform Med       Date:  2011-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.